Takanori Hidaka Selected Research

Takanori Hidaka Research Topics

Disease

16	Melanoma (Melanoma, Malignant) 01/2021 - 05/2011
16	Neoplasms (Cancer) 01/2021 - 05/2011
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 01/2017
3	Inflammation (Inflammations) 01/2019 - 01/2016
3	Extramammary Paget Disease (Paget Disease, Extramammary) 01/2019 - 11/2012
2	Carcinogenesis 01/2020 - 01/2019
2	Mycosis Fungoides 04/2018 - 09/2016
2	Carcinoma (Carcinomatosis) 01/2017 - 11/2012
1	Abscess 07/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Skin Neoplasms (Skin Cancer) 01/2019
1	Microsatellite Instability 01/2019
1	Dermatitis 01/2019
1	Turcot syndrome 01/2019
1	Uveitis 06/2018
1	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 06/2018
1	Lymphomatoid Papulosis 02/2018
1	Erythema 02/2018
1	Adenocarcinoma 01/2018
1	Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris) 09/2017
1	Keratoacanthoma 09/2017
1	Adrenocorticotropic hormone deficiency 03/2017
1	Ulcer 01/2017
1	Pruritus (Itching) 01/2017
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2017
1	Lymphoma (Lymphomas) 01/2017
1	Atopic Dermatitis (Atopic Eczema) 01/2017
1	Hypersensitivity (Allergy) 01/2017
1	Acquired ichthyosis 01/2017
1	Dermatomyositis (Dermatopolymyositis) 01/2017
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 09/2016
1	Liver Diseases (Liver Disease) 09/2016
1	Hemangiosarcoma (Angiosarcoma) 01/2012

Drug/Important Bio-Agent (IBA)

10	NivolumabIBA 01/2019 - 09/2016
6	ChemokinesIBA 01/2021 - 09/2016
5	AntibodiesIBA 01/2021 - 09/2017
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
4	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2020 - 01/2017
3	LigandsIBA 01/2020 - 01/2019
3	pembrolizumabIBA 01/2019 - 01/2018
3	IpilimumabIBA 01/2019 - 09/2016
3	RANK LigandIBA 01/2018 - 01/2016
2	CytokinesIBA 01/2020 - 01/2018
2	Programmed Cell Death 1 ReceptorIBA 01/2019 - 01/2018
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 09/2017
2	trametinibIBA 06/2018 - 02/2018
2	dabrafenibIBA 06/2018 - 02/2018
2	Bexarotene (LGD1069)FDA Link 02/2018 - 01/2017
2	Denosumab FDA Link 01/2018 - 01/2017
2	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 11/2012
1	Immunoglobulin E (IgE)IBA 07/2021
1	Plasminogen Activator Inhibitor 1IBA 01/2021
1	PlasminogenIBA 01/2021
1	6-formylindolo(3,2-b)carbazoleIBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Histone Deacetylase InhibitorsIBA 01/2019
1	Proto-Oncogene Proteins B-rafIBA 01/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019
1	CaspasesIBA 01/2019
1	MitogensIBA 01/2019
1	CarcinogensIBA 01/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	HLA-DRB1*04 antigenIBA 06/2018
1	mogamulizumabIBA 04/2018
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 01/2018
1	VemurafenibIBA 09/2017
1	Immune Checkpoint InhibitorsIBA 05/2017
1	Prednisolone (Predate)FDA LinkGeneric 01/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2017
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2017
1	Nerve Growth Factors (Neurotrophins)IBA 01/2017
1	Imiquimod (Aldara)FDA LinkGeneric 01/2017
1	PeplomycinIBA 01/2017
1	Air Pollutants (Pollutants, Air)IBA 01/2017
1	Interferon-gamma (Interferon, gamma)IBA 09/2016
1	Interferon-alpha (Interferon Alfa)IBA 09/2016
1	Lapatinib (GW572016)FDA Link 11/2012
1	Metalloproteases (Metalloproteinases)IBA 11/2012
1	Capecitabine (Xeloda)FDA Link 11/2012
1	SodiumIBA 01/2012
1	Diphosphonates (Bisphosphonates)IBA 01/2012
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2012
1	Risedronic Acid (Actonel)FDA LinkGeneric 01/2012
1	Docetaxel (Taxotere)FDA Link 01/2012
1	Acetylmuramyl-Alanyl-IsoglutamineIBA 05/2011
1	Interleukin-12 (IL 12)IBA 05/2011

Therapy/Procedure

9	Therapeutics 01/2019 - 05/2011
3	Immunotherapy 01/2021 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2019 - 01/2017
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 04/2018 - 05/2017
2	Radiotherapy 01/2017 - 01/2012
1	Chemoprevention 01/2019
1	Phototherapy (Light Therapy) 02/2018
1	Oral Administration 01/2012